Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Capital Expenditures (2022 - 2025)

Praxis Precision Medicines has reported Capital Expenditures over the past 3 years, most recently at -$8000.0 for Q3 2025.

  • Quarterly results put Capital Expenditures at -$8000.0 for Q3 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $56000.0 (changed N/A YoY), and the annual figure for FY2025 was $56000.0, changed.
  • Capital Expenditures for Q3 2025 was -$8000.0 at Praxis Precision Medicines, down from $64000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for PRAX hit a ceiling of $444000.0 in Q4 2022 and a floor of -$399000.0 in Q3 2022.
  • Median Capital Expenditures over the past 3 years was $64000.0 (2025), compared with a mean of $78571.4.
  • Peak annual rise in Capital Expenditures hit 112.53% in 2023, while the deepest fall reached 112.53% in 2023.
  • Praxis Precision Medicines' Capital Expenditures stood at $444000.0 in 2022, then tumbled by 88.74% to $50000.0 in 2023, then crashed by 116.0% to -$8000.0 in 2025.
  • The last three reported values for Capital Expenditures were -$8000.0 (Q3 2025), $64000.0 (Q1 2025), and $50000.0 (Q3 2023) per Business Quant data.